Sri Lanka’s study: Sinopharm vaccine efficient against Delta variant
Posted on August 7th, 2021

Courtesy CGTN

Researchers from one of Sri Lanka’s leading universities, the Sri Jayewardenepura University, have found that China’s Sinopharm COVID-19 vaccine is highly efficient against the Delta variant which has become the dominant variant across the world. According to the study, 95 percent of individuals who received two doses of the Sinopharm vaccine have developed antibodies similar to a naturally infected COVID-19 person.

Leave a Reply

You must be logged in to post a comment.

 

 

Disclaimer: The comments contained within this website are personal reflection only and do not necessarily reflect the views of the LankaWeb. LankaWeb.com offers the contents of this website without charge, but does not necessarily endorse the views and opinions expressed within. Neither the LankaWeb nor the individual authors of any material on this Web site accept responsibility for any loss or damage, however caused (including through negligence), which you may directly or indirectly suffer arising out of your use of or reliance on information contained on or accessed through this Web site. All views and opinions presented in this article are solely those of the surfer and do not necessarily represent those of LankaWeb.com.

This entry was posted on Saturday, August 7th, 2021. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response.

Copyright © 2024 LankaWeb.com. All Rights Reserved. Powered by Wordpress